SV1997000035A - BIARIL ACETYLENE AS METALOPROTEASE MATRIX INHIBITORS - Google Patents
BIARIL ACETYLENE AS METALOPROTEASE MATRIX INHIBITORSInfo
- Publication number
- SV1997000035A SV1997000035A SV1997000035A SV1997000035A SV1997000035A SV 1997000035 A SV1997000035 A SV 1997000035A SV 1997000035 A SV1997000035 A SV 1997000035A SV 1997000035 A SV1997000035 A SV 1997000035A SV 1997000035 A SV1997000035 A SV 1997000035A
- Authority
- SV
- El Salvador
- Prior art keywords
- biaril
- metaloprotease
- acetylene
- matrix inhibitors
- matrix
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/76—Unsaturated compounds containing keto groups
- C07C59/90—Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Oncology (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Enzymes And Modification Thereof (AREA)
- Steroid Compounds (AREA)
Abstract
EL PRESENTE INVENTO SE REFIERE A INHIBIDORES DE ENZIMAS Y MS ESPECIFICAMENTE, COM NOVEDOSOS COMPUESTOS QUE CONTIENEN BIARILACETILENO O DERIVADOS DE LOS MISMOS PARA INHIBIR LAS METALOSPROTEASAS. DE MATRIZ.THE PRESENT INVENTION REFERS TO ENZYME INHIBITORS AND MORE SPECIFICALLY, WITH NOVEL COMPOUNDS CONTAINING BIARYLACETHYLENE OR DERIVED FROM THEM TO INHIBIT METALSPROTEASES. OF MATRIX.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US64502896A | 1996-05-15 | 1996-05-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
SV1997000035A true SV1997000035A (en) | 1999-01-14 |
Family
ID=24587368
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SV1997000035A SV1997000035A (en) | 1996-05-15 | 1997-05-12 | BIARIL ACETYLENE AS METALOPROTEASE MATRIX INHIBITORS |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP0912496A1 (en) |
JP (1) | JP3090957B2 (en) |
CN (1) | CN1139570C (en) |
AR (1) | AR007097A1 (en) |
AU (1) | AU710759B2 (en) |
BR (1) | BR9709077A (en) |
CA (1) | CA2253796C (en) |
CO (1) | CO5080759A1 (en) |
HN (1) | HN1997000088A (en) |
HR (1) | HRP970245B1 (en) |
ID (1) | ID16910A (en) |
PA (1) | PA8429301A1 (en) |
SV (1) | SV1997000035A (en) |
TN (1) | TNSN97084A1 (en) |
TW (1) | TW381079B (en) |
WO (1) | WO1997043245A1 (en) |
YU (1) | YU18697A (en) |
ZA (1) | ZA974031B (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6288063B1 (en) | 1998-05-27 | 2001-09-11 | Bayer Corporation | Substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors |
US6326516B1 (en) | 1999-01-27 | 2001-12-04 | American Cyanamid Company | Acetylenic β-sulfonamido and phosphinic acid amide hydroxamic acid TACE inhibitors |
AR035478A1 (en) * | 1999-01-27 | 2004-06-02 | Wyeth Corp | AMIDA-HYDROXAMIC ACID, ACETYLLENE, BETA-SULPHONAMIDE AND PHOSPHINIC ACID AS INHIBITORS OF TACE, USE OF THE SAME FOR THE MANUFACTURE OF A MEDICINAL PRODUCT AND PHARMACEUTICAL COMPOSITION CONTAINING THEM |
EP1031349A1 (en) * | 1999-02-25 | 2000-08-30 | Bayer Aktiengesellschaft | Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives for the treatment of cerebral diseases |
US7141607B1 (en) | 2000-03-10 | 2006-11-28 | Insite Vision Incorporated | Methods and compositions for treating and inhibiting retinal neovascularization |
ES2592154T3 (en) | 2010-07-08 | 2016-11-28 | Kaken Pharmaceutical Co., Ltd. | N-Hydroxyformamide derivative and medicine containing the same |
US20170119776A1 (en) | 2014-04-03 | 2017-05-04 | Bayer Pharma Aktiengesellschaft | Chiral 2,5-disubstituted cyclopentanecarboxylic acid derivatives and use thereof |
CA2944614A1 (en) | 2014-04-03 | 2015-10-08 | Bayer Pharma Aktiengesellschaft | 2,5-disubstituted cyclopentane carboxylic acids for the treatment of respiratoy tract diseases |
WO2015150363A1 (en) | 2014-04-03 | 2015-10-08 | Bayer Pharma Aktiengesellschaft | 2,5-disubstituted cyclopentane carboxylic acids and use thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3784701A (en) * | 1970-09-21 | 1974-01-08 | American Cyanamid Co | Compositions containing substituted benzoylpropionic acids and method of use to treat inflammation and pain |
DE2112716A1 (en) * | 1971-03-17 | 1972-10-05 | Thomae Gmbh Dr K | Biphenylyl-butyric acid derivs. - anti phlogistics |
US5789434A (en) * | 1994-11-15 | 1998-08-04 | Bayer Corporation | Derivatives of substituted 4-biarylbutyric acid as matrix metalloprotease inhibitors |
-
1997
- 1997-05-09 CO CO97025172A patent/CO5080759A1/en unknown
- 1997-05-09 ZA ZA9704031A patent/ZA974031B/en unknown
- 1997-05-09 TN TNTNSN97084A patent/TNSN97084A1/en unknown
- 1997-05-09 HR HR970245A patent/HRP970245B1/en not_active IP Right Cessation
- 1997-05-12 PA PA19978429301A patent/PA8429301A1/en unknown
- 1997-05-12 YU YU18697A patent/YU18697A/en unknown
- 1997-05-12 AR ARP970101977A patent/AR007097A1/en unknown
- 1997-05-12 HN HN1997000088A patent/HN1997000088A/en unknown
- 1997-05-12 CN CNB971964564A patent/CN1139570C/en not_active Expired - Fee Related
- 1997-05-12 SV SV1997000035A patent/SV1997000035A/en unknown
- 1997-05-12 TW TW086106283A patent/TW381079B/en not_active IP Right Cessation
- 1997-05-12 JP JP09540980A patent/JP3090957B2/en not_active Expired - Fee Related
- 1997-05-12 BR BR9709077A patent/BR9709077A/en not_active Application Discontinuation
- 1997-05-12 EP EP97923622A patent/EP0912496A1/en not_active Withdrawn
- 1997-05-12 WO PCT/US1997/007921 patent/WO1997043245A1/en not_active Application Discontinuation
- 1997-05-12 AU AU29386/97A patent/AU710759B2/en not_active Ceased
- 1997-05-12 CA CA002253796A patent/CA2253796C/en not_active Expired - Fee Related
- 1997-05-14 ID IDP971606A patent/ID16910A/en unknown
Also Published As
Publication number | Publication date |
---|---|
ZA974031B (en) | 1998-02-19 |
TW381079B (en) | 2000-02-01 |
PA8429301A1 (en) | 2000-05-24 |
ID16910A (en) | 1997-11-20 |
BR9709077A (en) | 1999-08-03 |
AR007097A1 (en) | 1999-10-13 |
JPH11511179A (en) | 1999-09-28 |
HN1997000088A (en) | 1997-06-18 |
YU18697A (en) | 1999-11-22 |
HRP970245B1 (en) | 2002-06-30 |
JP3090957B2 (en) | 2000-09-25 |
CN1139570C (en) | 2004-02-25 |
CO5080759A1 (en) | 2001-09-25 |
AU2938697A (en) | 1997-12-05 |
CA2253796A1 (en) | 1997-11-20 |
HRP970245A2 (en) | 1998-04-30 |
TNSN97084A1 (en) | 2005-03-15 |
CA2253796C (en) | 2003-10-28 |
AU710759B2 (en) | 1999-09-30 |
CN1225623A (en) | 1999-08-11 |
WO1997043245A1 (en) | 1997-11-20 |
EP0912496A1 (en) | 1999-05-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2196630T3 (en) | ISOTIAZOLCARBOXIAMIDAS AND ITS EMPLOYMENT FOR THE PROTECTION OF PLANTS. | |
ES2196502T3 (en) | COMPOSITION AND METHOD TO INHIBIT THE DEVELOPMENT OF MICROORGANISMS THAT INCLUDES STABILIZED SODIUM HYPOOBROMYTE AND ISOTIAZOLONES. | |
ES2175443T3 (en) | NAPTOPIRAN COMPOUNDS AND ARTICLES CONTAINING THEM. | |
SV1996000026A (en) | BENZOCICLOPENTAN OXAZOLIDINONES CONTAINING HETEROATOMES | |
ES2179088T3 (en) | FLSA2 INHIBITORS 1H-INDOL-3-GLIOXYLAMIDE. | |
ES2196593T3 (en) | MODIFIED CARBON PRODUCTS WITH OUTGOING GROUPS FOR DYES AND COATINGS. | |
SV1998000008A (en) | SULFAMIDE-METALOPROTEASE INHIBITORS. REF. RAN 4070 \ 114 | |
PA8468401A1 (en) | COMPOUNDS FOR THE TREATMENT OF ISCHEMIA | |
ES2164182T3 (en) | BENZOCICLOPENTANOXAZOLIDINONES THAT CONTAIN HETEROATOMOS WITH ANTIBACTERIAL ACTIVITY. | |
ES2103152T3 (en) | USE OF SALICILIC ACID DERIVATIVES FOR SKIN DEPIGMENTATION. | |
ES2184888T3 (en) | EMPLOYMENT OF TIN CATALYSTS, AS WELL AS RETICULABLE MIXTURES CONTAINING THESE CATALYSTS. | |
HN1999000106A (en) | HETERO-CYCLE COMPOUNDS AS ROTAMASE ENZYME INHIBITORS. | |
ES2189476T3 (en) | GASES ODORIZED. | |
SV1997000035A (en) | BIARIL ACETYLENE AS METALOPROTEASE MATRIX INHIBITORS | |
UY27894A1 (en) | CINAMIDE DERIVATIVES | |
MX9307232A (en) | ARILCICLOALQUILAMINAS N, N-DISSTITUTED, ITS SALTS, MEDICINES CONTAINED IN THESE COMPOUNDS AND THEIR USE, AS WELL AS PROCEDURES FOR THEIR PREPARATION. | |
ES2074060T3 (en) | NEW CYAN AND ALENYL DERIVED FROM ARISTEROMYCIN / ADENOSINE ACETYLENE. | |
ES2153748A1 (en) | Synergistic stabilizer mixture based on polyalkyl-1-oxa-diazaspirodecane compounds | |
GT199900011A (en) | NEW DERIVATIVES OF DIHYDROXYHEXANIC ACID | |
ES2179138T3 (en) | POLYISOCIANATES THAT PRESENT ALOFANATO GROUPS BASED ON DIFENYLMETHANODIISOCIANATE WITH PREDOMINATING OR COMPLETELY BLOCKED ISOCIANATE GROUPS. | |
ES2184126T3 (en) | DERIVATIVES OF 3-MERCAPTOACETILAMINO-1,5-SUBSTITUTED-2-OXO-AZEPAN USEFUL AS METALOPROTEINASE INHIBITORS OF THE MATRIX. | |
MX9305093A (en) | NEW DERIVATIVESINDANO-2 MERCAPTOACETILAMINA TRICICLICOS 2-SUBSTITUTED, USEFUL AS ENCEPHALINASE INHIBITORS. | |
ATE68200T1 (en) | ANTIOXIDANT PRODUCTS. | |
GT199900113A (en) | FKBP INHIBITORS. | |
MX9304152A (en) | ENZYME INHIBITORS. |